Dokter Nele Myngheer, Endocrino-diabetologie
0739.798.511 · rovalta.com · 28/09/2026
ACTIVE
Dokter Nele Myngheer, Endocrino-diabetologie
Financial year 2025 · Closed on 31/12/2025
Net result353,7 k €+2,0 %over 1 year
Gross margin502,3 k €-8,4 %over 1 year
Equity61 k €-92,5 %over 1 year
Overview
Identity
Source · BCE/KBODokter Nele Myngheer, Endocrino-diabetologie is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Kortrijk.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0739.798.511
- Incorporation
- 19/12/2019
- Legal form
- Private limited company
- Registered office
- Lindestuk(Mar) 4
8510 Kortrijk · FlandreSee on map - Contributed capital
- 5 000,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 502,3 k € | -8.4% | 548,5 k € | +15.4% | 475,2 k € | +16.6% | 407,5 k € | -46.8% | 766,5 k € |
| EBITDA | 482,4 k € | -8.7% | 528,6 k € | +16.0% | 455,6 k € | +18.3% | 385,1 k € | -48.6% | 749,8 k € |
| Operating result | 416,4 k € | -9.8% | 461,6 k € | +16.3% | 396,9 k € | +20.0% | 330,7 k € | -52.5% | 696,6 k € |
| Net result | 353,7 k € | +2.0% | 346,9 k € | +15.4% | 300,5 k € | +19.6% | 251,2 k € | -51.9% | 522,4 k € |
| Balance sheet | |||||||||
| Equity | 61 k € | -92.5% | 817,4 k € | -8.2% | 890,5 k € | -25.2% | 1,2 M € | +26.8% | 938,8 k € |
| Total assets | 1,2 M € | -12.1% | 1,3 M € | +16.0% | 1,1 M € | -27.1% | 1,6 M € | +9.7% | 1,4 M € |
| Cash | 151 k € | -56.4% | 346,7 k € | +49.6% | 231,7 k € | -68.6% | 737,5 k € | +42.8% | 516,5 k € |
| Debts | 1,1 M € | +116% | 514,5 k € | +99.9% | 257,4 k € | -33.2% | 385,6 k € | -22.4% | 497,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Nele Myngheer | Directorsince 19/12/2019 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 19/12/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 13 months |
| Filing date | 22/07/2026 | 28/08/2025 | 08/09/2024 | 29/09/2023 | 31/08/2022 | 31/08/2021 |
| General meeting | 26/06/2026 | 27/06/2025 | 28/06/2024 | 30/06/2023 | 24/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 26/06/2026 | 22/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 27/06/2025 | 28/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 28/06/2024 | 08/09/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/06/2023 | 29/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 24/06/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 25/06/2021 | 31/08/2021 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Nele Myngheer | Directorsince 19/12/2019 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other23/12/2019RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings6 filings
Mandates
Nele Myngheer
20192020202120222023202420252026
Dokter Nele Myngheer, Endocrino-diabetologieMyngheer Nele, Endocrino-diabetologie
Lindestuk(Mar) 4, 8510 Marke
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Lindestuk(Mar) 4, 8510 MarkeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00318766 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokter Nele Myngheer, Endocrino-diabetologieCurrent | accounts 2023 → 2025 | Accounts 2025 · 2026-00318766 |
| Myngheer Nele, Endocrino-diabetologie | accounts 2021 → 2022 | Accounts 2022 · 2023-00475068 |
Events
- 2025Annual accounts 2025353,7 k €↑
- 2024Annual accounts 2024346,9 k €↑
- 2023Annual accounts 2023300,5 k €↑
- 2023Name changeDokter Nele Myngheer, Endocrino-diabetologie
- 2022Annual accounts 2022251,2 k €↓
- 2021Annual accounts 2021522,4 k €↑
- 2020Annual accounts 2020411,4 k €
- 19/12/2019IncorporationPrivate limited company